Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II V
Sponsor: Genelux Corporation
Check if you qualify for this ovarian cancer clinical trial in Orlando, FL
If you're searching for ovarian cancer treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.